Skip to main content
FinSpry Logo
FinSpry
MIRM logo
MIRM
(NASDAQ)
Mirum Pharmaceuticals, Inc.
$100.90-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Mirum Pharmaceuticals (MIRM) Stock Price & Financial Analysis

Mirum Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$99.08 - $101.99
52-Week High$130.00
52-Week Low$63.23
Open$99.08
Volume343.86K
Average Volume (3M)624.55K
Market Cap5.94B
Shares Outstanding58.85M
Price to Sales (P/S)10.42
Price to Book (P/B)24.49
EV/EBITDA-7.80
Revenue (TTM)569.61M
Net Income (TTM)-798.84M
Free Cash Flow (TTM)-172.55M
EPS (TTM)$-14.81
Profit Margin-140.24%
Operating Margin-12.31%
Return on Equity (ROE)-329.43%
Debt to Equity1.34
50-Day MA$109.06
200-Day MA$96.06
52-Week Change32.66%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Mirum Pharmaceuticals

What is the current stock price for MIRM?

As of the latest trading session, MIRM stock trades at $100.90. The 52-week range is $63.23–$130.00, with a day range of $99.08–$101.99.

What is the P/E ratio for MIRM?

The P/E ratio (Price-to-Earnings) for MIRM is shown in the Key Statistics section. This valuation metric helps compare Mirum Pharmaceuticals, Inc. to industry peers.

Does MIRM pay dividends?

Mirum Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MIRM?

Based on 6 analysts, the consensus for MIRM is Buy.

What is the market cap of MIRM?

Mirum Pharmaceuticals's market capitalization is $5.94B, classifying it as a mid-cap company. Mirum Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.